There is a new clinical trial that is currently recruiting patients who suffer from Interstitial Cystitis with generalized vulvodynia. The purpose of the clinical trial (per the Clinical Trials.gov website):
In order to investigate whether the pain in women with vulvodynia may represent bladder origin pain, we will be performing a diagnostic test for interstitial cystitis (IC) in women with generalized vulvodynia. Those women with a positive test for IC, we will be performing a series of bladder treatments (instillations) for IC and checking symptoms throughout the trial to see if significant relief of vulvar pain can be obtained through treatment for IC.
We plan to enroll women 18 years or older with GV and negative tests for urine infection, negative cultures for Chlamydia and gonorrhea when indicated, and negative screens or cultures for yeast infection or bacterial vaginosis when indicated. Patient symptoms will need to include no or minimal vaginal discharge. Patients will have a minimum Visual Analog Score for vulvar pain of at least 3/10. In order to receive bladder instillations, patients will need to have a positive potassium sensitivity test.
We will exclude patients from enrollment if they use chronic narcotic pain medication or have localized vulvodynia. (We believe that localize vulvodynia is less likely of bladder origin).
If you would like more information on this clinical trial, or to be considered for it, refer to the clinical trial ID #NCT01048177 when inquiring to the names listed below:
Bruce Kahn, M.D. 858-764-9080 firstname.lastname@example.org
Nancy Giovanetty 858-764-9080 email@example.com